Jump to navigation

  • IHME
  • GHDx
  • GBD Compare
Home
Main menu
  • Home
  • Results
    • GBD Results Tool
    • Data Visualizations
    • Country Profiles
    • GBD 2019 Cause and Risk Summaries
    • US Health
    • Policy Reports
    • Research Articles
    • Infographics
    • Topics
    • Data & Tools
  • News & Events
    • News
    • Commentaries
    • Events
    • Videos
    • Acting on Data
      • IHME Foundations
  • Projects
    • COVID-19 resources
    • Global Burden of Disease (GBD)
    • Center for Health Trends and Forecasts (CHTF)
    • Disease Control Priorities Network (DCPN)
    • View all
  • Get Involved
    • Donate
    • Careers
    • Call for Collaborators
    • The Roux Prize
    • Murray-Lopez Award
    • Online Training
    • Courses
    • Degree programs
    • Workshops
  • About
    • Racism is a public health issue.
    • Our Principles
    • Faculty
    • Senior Management Team
    • Governance
    • History
    • GHDx
    • Terms and Conditions
    • Contact Us

Explore section

Results

  • GBD Results Tool
  • Data Visualizations
  • Country Profiles
  • GBD 2019 Cause and Risk Summaries
  • US Health
  • Policy Reports
  • Research Articles
  • Infographics
  • Topics
  • Data & Tools

GBD 2019 Cause and Risk Summaries


Global Burden of Disease 2019 disease, injury, and impairment summaries

These two-page summaries offer a concise overview of causes, impairments, and risk factors modeled in GBD and the health loss related to them. The summaries include a summary results statement; a definition of the disease, injury, impairment, or risk; and a brief listing of modeling updates in GBD 2019 compared to previous GBD rounds. Tables and figures display metrics for each topic. Please use the menus below to select your topic of interest. To learn more about what the summaries include, please visit these pages: 

  • Learn more about GBD 2019 Disease, Injury, and Impairment Summaries
  • Learn more about GBD 2019 Risk Factor Summaries
Displaying 31 - 40 of 454

Asthma — Level 3 cause

Summary Asthma was responsible for 21·6 million (95% UI 17·1–27·0) DALYs in 2019, which was 20·8% (17·5–24·7) of total DALYs from chronic respiratory disease. Death rates from asthma were highest in countries of low and middle SDI, while prevalence was highest in high SDI countries. Definition...Read more

Atopic dermatitis — Level 4 cause

Summary Globally, atopic dermatitis was responsible for 7·48 million (95% UI 3·99–12·6) DALYs and 24·4 million (23·3–25·6) incident cases in 2019. Definition Atopic dermatitis is a relapsing dermatitis associated with elevated serum immunoglobulin E and some degree of immune dysregulation; it can...Read more

Atrial fibrillation and flutter — Level 3 cause

Summary There were 8·39 million (95% UI 6·69–10·5) DALYs due to atrial fibrillation and flutter in 2019, a 121·6% (111·5–132·0) increase from 1990. In 2019, there were 194 000 deaths (161 000–225 000) due to atrial fibrillation and flutter in females and 122 000 deaths (97 400–148 000) in males...Read more

Attention-deficit/hyperactivity disorder — Level 3 cause

Summary Attention-deficit/hyperactivity disorder (ADHD) resulted in 1·03 million (95% UI 0·58–1·74) global DALYs in 2019. ADHD contributed to 0·8% (0·5–1·4) of DALYs for the aggregate of mental disorders. Definition ADHD is an externalising disorder, incorporating disability from persistent...Read more

Autism spectrum disorders — Level 3 cause

Summary Autism spectrum disorders (ASD) resulted in 4·31 million (95% UI 2·82–6·23) global DALYs in 2019, equivalent to 0·2% (0·1–0·2) of DALYs. ASD contributed to 3·4% (2·7–4·3) of DALYs for the aggregate of mental disorders. Definition ASD are a group of neurodevelopmental disorders with onset...Read more

Bacterial skin diseases — Level 3 cause

Summary Globally, bacterial skin diseases were responsible for 2·20 million (95% UI 1·66–2·64) DALYs in 2019, with 551 000 (378 000–660 000) DALYs from cellulitis and 1·65 million (1·25–2.01) DALYs from pyoderma. Definition This aggregate cause includes death and disability resulting from...Read more

Benign and in situ cervical and uterine neoplasms — Level 4 cause

Summary There were 2·30 million (95% UI 1·70–3·03) incident cases of benign and in situ cervical and uterine neoplasms globally in 2019. Definition This cause includes disability resulting from any diagnosed non-invasive growth of the cervix or uterus, including ICD codes such as D06, D07.0, D26,...Read more

Benign and in situ intestinal neoplasms — Level 4 cause

Summary There were 8·46 million (95% UI 6·57–10·6) incident cases due to benign and in situ intestinal neoplasms globally in 2019. Definition This cause includes disability resulting from any non-invasive neoplasm of the intestines, including ICD-10 codes such as D01.0–D01.3, D12, K62.0–K62.1, and...Read more

Benign prostatic hyperplasia — Level 4 cause

Summary There were 94·0 million (95% UI 73·2–118) prevalent cases of benign prostatic hyperplasia in 2019, resulting in 1·86 million (1·13–2·78) global DALYs. Definition This Level 4 cause incorporates disability resulting from benign proliferation of prostatic tissue that can lead to bladder...Read more

Bipolar disorder — Level 3 cause

Summary Bipolar disorder resulted in 8·50 million (95% UI 5·20–13·0) global DALYs in 2019, equivalent to 0·3% (0·2–0·5) of DALYs. Bipolar disorder contributed to 6·8% (4·9–9·1) of DALYs for the aggregate of mental disorders. Definition Bipolar disorder is a mood disorder incorporating disability...Read more

Pages

  • « first
  • ‹ previous
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • …
  • next ›
  • last »

Results

  • GBD Results Tool
  • Data Visualizations
  • Country Profiles
  • GBD 2019 Cause and Risk Summaries
  • US Health
  • Policy Reports
  • Research Articles
  • Infographics
  • Topics
  • Data & Tools

Stay connected

     

IHME

Institute for Health Metrics and Evaluation

Population Health Building/Hans Rosling Center

3980 15th Ave. NE, Seattle, WA 98195

UW Campus Box #351615

Tel: +1-206-897-2800

Fax: +1-206-897-2899

© 2020 University of Washington

  • Privacy policy
  • Login

  • Home
  • Results
    • GBD Results Tool
    • Data Visualizations
    • Country Profiles
    • GBD 2019 Cause and Risk Summaries
    • US Health
    • Policy Reports
    • Research Articles
    • Infographics
    • Topics
    • Data & Tools
  • News & Events
    • News
    • Commentaries
    • Events
    • Videos
    • Acting on Data
  • Projects
    • COVID-19 resources
    • Global Burden of Disease (GBD)
    • Center for Health Trends and Forecasts (CHTF)
    • Disease Control Priorities Network (DCPN)
    • View all
  • Get Involved
    • Donate
    • Careers
    • Call for Collaborators
    • The Roux Prize
    • Murray-Lopez Award
    • Online Training
    • Courses
    • Degree programs
    • Workshops
  • About
    • Racism is a public health issue.
    • Our Principles
    • Faculty
    • Senior Management Team
    • Governance
    • History
    • GHDx
    • Terms and Conditions
    • Contact Us

Projects

  • Global Burden of Disease (GBD)
  • Disease Control Priorities Network (DCPN)
  • ABCE+: A Focus on Antiretroviral Therapy (ART)
  • Access, Bottlenecks, Costs, and Equity (ABCE)
  • Efficacy to Effectiveness
  • Viral Load Pilot
  • Salud Mesoamérica Initiative
  • Improving Methods to Measure Comparable Mortality by Cause
  • Verbal Autopsy (VA)
  • Disease Expenditure (DEX)
  • Local Burden of Disease
  • State-level disease burden initiative in India
  • US Counties Drivers of Health Study
  • University of Washington Center for Health Trends and Forecasts